We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$2.47B
AUM Growth
-$289M
Cap. Flow
-$35.7M
Cap. Flow %
-1.44%
Top 10 Hldgs %
61.17%
Holding
110
New
16
Increased
30
Reduced
10
Closed
25

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$15.8M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$14.7M
3
INCY icon
Incyte
INCY
+$14.3M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$11.2M
5
TEX icon
Terex
TEX
+$6.1M

Top Sells

Rank Stock Value
1
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$78.4M
2
AMGN icon
Amgen
AMGN
+$17.4M
3
DG icon
Dollar General
DG
+$13.9M
4
MJN
Mead Johnson Nutrition Company
MJN
+$12.5M
5
BRFS
BRF SA
BRFS
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.5%
2 Consumer Discretionary 25.19%
3 Healthcare 24.49%
4 Financials 1.12%
5 Industrials 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXDX
76
DELISTED
Ignyta, Inc.
RXDX
$2.73M 0.11%
300,000
– –
STML
77
DELISTED
Stemline Therapeutics, Inc.
STML
$2.49M 0.1%
170,000
+15,000
+10% +$230K
SPHS
78
DELISTED
Sophiris Bio, Inc.
SPHS
$2.24M 0.09%
1,000,000
– –
SFXE
79
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$2.02M 0.08%
+250,000
New +$1.82M
AMBI
80
DELISTED
Ambit Biosciences Corp
AMBI
$1.73M 0.07%
250,000
– –
CCXI
81
DELISTED
ChemoCentryx, Inc.
CCXI
$1.61M 0.07%
275,000
– –
BAC icon
82
Bank of America
BAC
$412B
$1.54M 0.06%
+100,000
New +$1.55M
CSLT
83
CALL
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.52M 0.06%
+100,000
New +$1.63M
AGEN
84
Agenus
AGEN
$312M
$1.32M 0.05%
20,896
– –
AMRN
85
CALL
Amarin Corp
AMRN
$291M
$880K 0.04%
25,000
– –
AMGN icon
86
Amgen
AMGN
$204B
– –
-150,000
Closed -$17.4M
AMZN icon
87
CALL
Amazon
AMZN
$2.69T
– –
-3,000,000
Closed -$50.5M
BRFS
88
DELISTED
BRF SA
BRFS
– –
-446,900
Closed -$10.1M
CPAC
89
Cementos Pacasmayo
CPAC
$1.08B
– –
-205,580
Closed -$2.25M
DG icon
90
Dollar General
DG
$27.6B
– –
-250,000
Closed -$13.9M
EWW icon
91
CALL
iShares MSCI Mexico ETF
EWW
$1.71B
– –
-150,000
Closed -$9.59M
FXI icon
92
CALL
iShares China Large-Cap ETF
FXI
$4.11B
– –
-200,000
Closed -$7.16M
GS icon
93
CALL
Goldman Sachs
GS
$279B
– –
-125,000
Closed -$20.5M
HAL icon
94
CALL
Halliburton
HAL
$29.7B
– –
-150,000
Closed -$8.83M
HIG icon
95
CALL
Hartford Financial Services
HIG
$36.8B
– –
-500,000
Closed -$17.6M
HOUS
96
DELISTED
Anywhere Real Estate
HOUS
– –
-150,000
Closed -$5.82M
IBB icon
97
CALL
iShares Biotechnology ETF
IBB
$10.3B
– –
-900,000
Closed -$70.9M
INTC icon
98
CALL
Intel
INTC
$518B
– –
-750,000
Closed -$19.4M
M icon
99
CALL
Macy's
M
$5.71B
– –
-100,000
Closed -$5.93M
MTG icon
100
MGIC Investment
MTG
$5.99B
– –
-600,000
Closed -$5.11M
1 2 3
4
5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Artal Group's Q2 2014 Portfolio in Review

As of Q2 2014, Artal Group held 110 positions worth $2.47B, down 10% from $2.76B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Artal Group's Q2 2014 filing shows 16 new, 30 increased, 10 reduced and 25 closed positions. Its largest new stake was Amazon: 1,000,000 shares worth $16.2M. The largest sale was FURIEX PHARMACEUTICALS INC COM STK (DE), an estimated $78.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 53% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Artal Group's largest Q2 2014 buy was Amazon: 1,000,000 shares worth $16.2M.
  • Artal Group added most to AUXILIUM PHARAMCEUTICALS INC in Q2 2014, an estimated $14.7M increase.
  • Artal Group's biggest Q2 2014 reduction was Ralph Lauren, cutting an estimated $3.85M.
  • Artal Group fully exited FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014, selling an estimated $78.4M.
  • Artal Group's ten largest holdings make up 61% of its $2.47B portfolio in Q2 2014.
  • Artal Group opened 16 new positions and closed 25 in Q2 2014.
  • Artal Group's portfolio value fell 10% quarter-over-quarter to $2.47B.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.